TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Na
Information relative au nombre total des droits de vote et d’actions composant le capital social au 31 décembre 2025

DBV Technologies announced positive topline results from its Phase 3 VITESSE trial evaluating VIASKIN® Peanut Patch for treating peanut allergies in children aged 4-7 years. The trial met its primary endpoints, representing a significant milestone for the company's immunotherapy treatment program.

Insights
ACHR.WS   positive

The article suggests potential 50% stock price growth by 2026, highlighting the company's progress in developing electric vertical takeoff and landing (eVTOL) aircraft, advancing from prototypes to production, and exploring initial operational routes


DBVT   positive

The company announced positive topline results from a Phase 3 clinical trial, which is a significant regulatory and clinical milestone. Successful Phase 3 trial outcomes typically support potential regulatory approval and commercialization prospects, representing material positive news for the company's pipeline and future revenue potential.